SEC Form 4 · accession 0001258693-26-000019
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Grant Pickering
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Sep 8, 2026
Accepted (ET)
Sep 9, 2026 · 5:56 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2026 | F | 17,056 | $60.36 | D | 429,902 | D | |
| Common StockF2 | holding | — | — | — | 133,215 | I | By Children's Trust | |
| Common StockF3 | holding | — | — | — | 133,215 | I | By Children's Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F2Shares are held directly by a trust for the benefit of the Reporting Person's son.
- F3Shares are held directly by a trust for the benefit of the Reporting Person's daughter.